FDA Inspection 1055920 — Janssen Pharmaceutica, N.V.
The FDA completed an inspection of Janssen Pharmaceutica, N.V. on June 12, 2018 in Beerse. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 12, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Beerse (Belgium)